Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins

High-grade serous ovarian carcinoma (HGSOC) is the most common and deadliest ovarian cancer subtype. Despite advances in treatment, the overall prognosis remains poor. Regardless of efforts to develop biomarkers to predict surgical outcome and recurrence risk and resistance, reproducible indicators...

Descripción completa

Detalles Bibliográficos
Autores principales: Torkildsen, Cecilie Fredvik, Austdal, Marie, Iversen, Ann-Charlotte, Bathen, Tone Frost, Giskeødegård, Guro Fanneløb, Nilsen, Elisabeth Berge, Iversen, Grete Alræk, Sande, Ragnar Kvie, Bjørge, Line, Thomsen, Liv Cecilie Vestrheim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053757/
https://www.ncbi.nlm.nih.gov/pubmed/36984856
http://dx.doi.org/10.3390/metabo13030417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053757/
https://www.ncbi.nlm.nih.gov/pubmed/36984856
http://dx.doi.org/10.3390/metabo13030417

Ejemplares similares